These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 8784098)

  • 21. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
    Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
    Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC
    Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women.
    Wu N; Wang QP; Li H; Wu XP; Sun ZQ; Luo XH
    Clin Chim Acta; 2010 May; 411(9-10):771-5. PubMed ID: 20184866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis.
    Eviö S; Tiitinen A; Laitinen K; Ylikorkala O; Välimäki MJ
    J Clin Endocrinol Metab; 2004 Feb; 89(2):626-31. PubMed ID: 14764773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women.
    Morgante G; La Marca A; Ditto A; Musacchio MC; Cavicchioli C; Lanzetta D; Petraglia F; De Leo V
    Gynecol Endocrinol; 2001 Dec; 15(6):466-71. PubMed ID: 11826771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
    Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
    Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian aging and bone metabolism in menstruating women aged 35-50 years.
    Vural F; Vural B; Yucesoy I; Badur S
    Maturitas; 2005 Oct; 52(2):147-53. PubMed ID: 16186077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone loss in premenopausal, perimenopausal and postmenopausal women: results of a prospective observational study over 9 years.
    Seifert-Klauss V; Fillenberg S; Schneider H; Luppa P; Mueller D; Kiechle M
    Climacteric; 2012 Oct; 15(5):433-40. PubMed ID: 22443333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
    Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
    Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.
    Sowers MR; Greendale GA; Bondarenko I; Finkelstein JS; Cauley JA; Neer RM; Ettinger B
    Osteoporos Int; 2003 May; 14(3):191-7. PubMed ID: 12730778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.
    Rogers A; Saleh G; Hannon RA; Greenfield D; Eastell R
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.